Except for ASPH, MT2A (Supplementary Figure 5A, 5B), the other 9 genes’ high expressions were significantly correlated with a poor prognosis of NSCLC patients (Figure 4B–4J). This evidence concerns the gene MT2A and non-small cell lung carcinoma.